Pharmaceutical R&D: Costs, Risks, and Rewards (1993)

Chapter: APPENDIX E: Patent Protection of Pharmaceuticals in the United States

Previous Chapter: APPENDIX D: Congressional Access to Proprietary Pharmaceutical Industry Data
Suggested Citation: "APPENDIX E: Patent Protection of Pharmaceuticals in the United States." National Research Council. 1993. Pharmaceutical R&D: Costs, Risks, and Rewards. Washington, DC: The National Academies Press. doi: 10.17226/20876.
Page 290
Suggested Citation: "APPENDIX E: Patent Protection of Pharmaceuticals in the United States." National Research Council. 1993. Pharmaceutical R&D: Costs, Risks, and Rewards. Washington, DC: The National Academies Press. doi: 10.17226/20876.
Page 291
Suggested Citation: "APPENDIX E: Patent Protection of Pharmaceuticals in the United States." National Research Council. 1993. Pharmaceutical R&D: Costs, Risks, and Rewards. Washington, DC: The National Academies Press. doi: 10.17226/20876.
Page 292
Suggested Citation: "APPENDIX E: Patent Protection of Pharmaceuticals in the United States." National Research Council. 1993. Pharmaceutical R&D: Costs, Risks, and Rewards. Washington, DC: The National Academies Press. doi: 10.17226/20876.
Page 293
Next Chapter: APPENDIX F: Summary of Methods Used to Analyze Trends in Postpatient Revenues
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.